Couverture de GLP-1 Drugs Explained — The Complete Guide

GLP-1 Drugs Explained — The Complete Guide

GLP-1 Drugs Explained — The Complete Guide

De : Inception Point Ai
Écouter gratuitement

À propos de ce contenu audio

 Discover the science behind GLP-1 drugs like Ozempic, Wegovy, and Mounjaro with Dr. Ben Synth. Understand how these medications work at the molecular level, why they're so effective for weight loss and diabetes, and what the expanding research means for conditions from heart disease to Alzheimer's.

For more content like this, visit QuietPlease.aiCopyright 2025 Inception Point Ai Hygiène et vie saine Maladie et pathologies physiques Science
Épisodes
  • GLP-1 Drugs Explained — The Complete Guide - Navigate the science behind the breakthrough with Dr. Ben Synth

    GLP-1 Drugs Explained — The Complete Guide - Navigate the science behind the breakthrough with Dr. Ben Synth
    Apr 7 2026
    Join Dr. Ben Synth as he breaks down the science behind GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound—explaining how these game-changing drugs work, what makes them different, and why they're being tested for everything from heart disease to Alzheimer's. Clear, jargon-free insights into a medical revolution.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    Afficher plus Afficher moins
    1 min
  • GLP-1 Drugs Explained — The Complete Guide - The Head-to-Head Breakdown

    GLP-1 Drugs Explained — The Complete Guide - The Head-to-Head Breakdown
    Apr 7 2026
    Host Ben Synth breaks down the science behind Ozempic, Wegovy, Mounjaro, and Zepbound—four brand names for two molecules. Learn how semaglutide and tirzepatide work, what clinical trials reveal about their effectiveness for diabetes and weight loss, why dual agonists may outperform single agonists, and which drug suits different patient needs based on real data, not celebrity gossip.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    Afficher plus Afficher moins
    21 min
Aucun commentaire pour le moment